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Abstract
Although the immune component of the pathogenesis of schizophrenia is well documented and recognized, the characteristics 
of the relationship between nonspecific and specific immune resistance and their correlation with the form and course of the 
disease continue to remain practically unexplored. 
The aim of this study was to investigate the systemic relationships present between the multiple parameters of the immune 
system (cellular, humoral and phagocytic defenses, the serum levels of the antibodies to herpes simplex virus type 1, herpes 
simplex virus type 2, cytomegalovirus  and  Epstein-Barr virus) in episodic remittent paranoid schizophrenia (ERPS) compared 
with unfavorably current form of episodic paranoid schizophrenia with progressive or stable deficit (EPSPSD). 
Material and Methods: The study included 32 patients with ERPS (main group) and 30 patients with EPSPSD (control 
group). We determined the leukocyte content, the lymphocyte subpopulations and the leukocyte phagocytosis in PHAGOTEST 
with fluorescein (FITC)-labeled opsonized bacteria and calculated the phagocytic index (PhI), the circulating immune complexes 
(CIC) level by spectrophotometry. The antibodies against the herpesviruses (HSV-1, HSV-2, CMV, EBV) were determined using 
the ELISA test. Total serum immunoglobulins, IgG, IgM, and IgA, were determined by immunoturbidimetry.
Results: In the main group, a combination of immune responses to the viruses studied was observed, while in the control 
group, an immune response to herpes simplex virus type 1 (HSV-1) -  herpes simplex virus type 2 (HSV-2) - cytomegalovirus   
(CMV) association was found, as well as an immune response separately to Epstein-Barr virus (EBV). In both groups, the cellular 
immune deficit was noted to be more pronounced in the control group. 
Conclusion: These results demonstrate a definite link between herpes infection and the immune resistance parameters of 
patients with the episodic paranoid schizophrenia. The results confirm the infectious theory of the diseases.
Keywords: schizophrenia; immune system; herpesviruses; HSV-1; HSV-2; CMV; EBV.
Introduction
Research  is  currently  underway  to  determine  the 
importance  of  pathology  of  immune  response  in  the 
pathogenesis of schizophrenia. The imbalance of the T-helper 
cells, types 1 and 2, leading to T-cell immunity deficit and 
humoral activation, has been reported to be the main pattern 
of this disease. The link between the immune reactivity and 
clinical forms and course of the disease has now been revealed 
[1,2].  In  particular,  the  low  natural  killer  cell  cytotoxic 
activity occurs right during the first episode of schizophrenia 
[3]. This parameter becomes normalized by the influence of 
serotonin [4]. Based on the analysis of numerous studies, the 
association of schizophrenia with an autoimmune process was 
discovered [5]. In particular, a tendency for the serum level 
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of CIC to increase in schizophrenic patients was revealed. A 
direct correlation was noted between the CIC serum level and 
disease duration [6].
Several  studies  have  described  the  activation  of  an 
innate immunity in the form of the high degranulating activity 
of the leukocyte elastase and functional activity of the alpha 
1-proteinase  inhibitor.  The  high  degree  of  the  leukocyte 
elastase  activity  and  the  high  level  of  auto-antibodies 
produced in response to the nerve growth factor were found to 
correspond to the increase in the extent of the progression of 
the schizophrenia [7-9].
In our prior study [9], in patients revealing schizophrenia 
exacerbations, a clear tendency for the increased values in the 
titers  of  the  neurotropic  autoantibodies  (IgG)  in  the  “ELI-
N-Test 12” (Russia - [10]) was revealed. The autoantibody 
complexes, whose titers were frequently elevated, reflected the 
connection between the autoimmune process in schizophrenia 
with neurodegeneration, demyelination and glial activation, 
as well indicated the signs of cerebral vasculitis described in 
other disciplinary approaches. However, the data indicating 
the presence of viral infections in patients with schizophrenia 
was also recorded [9]. This fact, in this context, is of particular 
interest because recent studies have reported an association 
of  autoimmune  diseases  with  the  preceding  infectious  and 
inflammatory processes involving viruses, in particular, EBV 
[10-11].
The  neurochemical  changes  in  the  brain  structures 
associated  with  mental  disorder  are  now  being  considered 
as one of the possible reasons for the immune disorders in 
schizophrenia [12]. A number of researchers tend to assume 
immune dysfunction as the primary disorder and presuppose 
their  genetic  nature  [13,14].  Another  hypothesis  is  the 
association of the immune pathology with the chronic infectious 
process  in  the  prenatal  period  (one  of  the  possibilities) 
accompanied  by  the  transfer  of  the  genetic  material  of  an 
infectious agent along with the parental chromosomes [15-
18]. Indeed, patients with schizophrenia revealed much higher 
antibody  levels  with  respect  to  the  neurotrophic  infectious 
agents than do the healthy individuals [19-21]. This enabled 
the authors to conclude that these infectious agents played a 
possible significant role in the pathogenesis of schizophrenia. 
Besides,  some  data  characterizing  the  correlation  of  the 
clinical and immunological parameters with the serum level 
of the antibodies to herpesviruses was obtained. Thus, positive 
correlations were established between the HSV-1 IgG antibody 
titers  and  the  severity  of  the  violations  of  some  cognitive 
functions in schizophrenia [22, 23], as well as between the 
EBV IgG antibody levels and the severity of the psychotic 
symptoms in boys [24].
Some studies focused upon the various aspects of the 
immune  response  to  CMV  in  patients  with  schizophrenia. 
Their  results  indicate  a  cellular  immune  deficit  and  low 
cytotoxic activity of the natural killer cells together with the 
tendency to reduce the degree of gamma interferon production 
in patients with the first-episode of juvenile schizophrenia [3, 
25]. An association between the immunological parameters, 
CMV activity and the dynamics of therapy with psychotropic 
drugs was revealed [13].
  In  light  of  the  correlation  between  the  clinical  and 
immunological parameters being clearly defined, the positive 
effect of immunomodulators (Cicloferon, Thymogenum and 
Aferon) has been associated with the therapy of schizophrenia 
exacerbations [12, 26]. The efficacy of the acyclovir derivatives 
in  schizophrenia,  however,  is  currently  controversial  [27, 
28] Additionally, according to virologists [29, 30], cellular 
immunity  deficit,  which  is  formed  in  individuals  with 
persistent herpes infections, is a well-known phenomenon.
 The listed data indicate the possible role of the herpes 
virus  infection  as  an  etiopathogenetic  factor  determining 
the formation of multiple immune disorders leading to the 
impairment of the functioning of the brain structures and the 
subsequent development of the psychopathological symptoms.
The aim of this study was to investigate the systemic 
relationships present between the multiple parameters of the 
immune system (cellular, humoral and phagocytic defenses, 
the serum levels of the antibodies to HSV-1, HSV-2, CMV, and 
EBV) in episodic remittent paranoid schizophrenia (ERPS) 
compared with unfavorably current form of episodic paranoid 
schizophrenia with progressive or stable deficit (EPSPSD). 
Material and Methods
The  study  included  32  patients  with  ERPS  (F20.03) 
(main group) and 30 patients with EPSPSD (F20.00, F20.01) 
(control  group). The  patients  were  examined    during  their 
admission for inpatient treatment at the “Mental Health” clinic 
in connection with the acute exacerbations of schizophrenia or 
the very first manifestation of the disease between 2009 and 
2011. The clinical diagnosis of schizophrenia was conducted 
in accordance with the ICD-10 criteria. The patients ranged 
from 18 to 58 years in age, with patients between 18 and 39 
years being more prevalent (n=57). The average duration of 
the disease from the first manifestation did not exceed 9 years 
(Table 1). In total, 17 patients were admitted to a psychiatric 
hospital for the first time and had never taken psychotropic 
drugs. The other 19 patients had taken psychotropic drugs 
irregularly during the remission, although prior to entering the 
hospital, they had refrained from taking them. 
The syndromal psychiatric assessment of the patients in both 
groups at the time of examination is reflected in Table 1. The BPRS 
scale was used to assess the severity of the psychopathology. 
Table 1.
Demographic and clinical characteristics of patients with 
schizophrenia 
Variable ERPS EPSPSD  Total
Number of patients 32 30 62
Sex
Male 15 14 29
Female 15 18 33
Age range, (yr) 18-51 18-58 18-58
Mean age,(yr) 29.6±8.85 31.5±9 30.5± 9.3
Duration of disease, (yr) 4.9±5 8.9±3 7±7.7
Main 
syndrome
Catatonic-paranoid 8 2 10
Hallucinatory – 
Delusional
15 3 18
Affective- 
Delusional
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The  average  global  assessment  of  severity  of  the 
psychopathological symptoms was 3.4±2.3 points in the main 
group and 4.8±0.5 points in the control group. Severe somatic 
diseases, organic diseases of the central nervous system, as 
well as alcohol and drug addiction were not identified in any 
of  the  cases  studied. All  the  patients  belonged  to  families 
holding a high socio-economic status. 
Immunological methods
We determined the leukocyte content, the lymphocyte 
subpopulations  and  the  leukocyte  phagocytosis  in 
PHAGOTEST  with  fluorescein  (FITC)-labeled  opsonized 
bacteria and calculated the phagocytic index (PhI), the CIC 
level by spectrophotometry. The antibodies (Ab) against the 
herpesviruses (HSV-1, HSV-2, CMV, EBV) were determined 
using  the  ELISA  test.  Total  serum  immunoglobulins,  IgG, 
IgM, and IgA, were determined by immunoturbidimetry.
 Results were statistically processed using the software 
package  Statistica  6.0  for  Windows. The  mean  (M)  and 
standard deviation (SD) was deduced. For data with normal 
distribution, inter-group comparisons were performed using 
Student’s  t-test.  The  Mann-Whitney  (U  Test)  was  used 
to  compare  the  differences  between  the  two  independent 
groups (for nonparametric data). Spearman’s rank correlation 
coefficient was also used. Pearson’s Correlation Coefficient 
(r)  was  used  to  determine  the  strength  of  the  relationship 
between the two continuous variables.  A value of P<0.05 
was  considered  statistically  significant.  Correlations  were 
calculated  for  the  quantitative  indicators  of  immunity, 
regardless of whether they exceed the reference values.
Results and Discussion
We  analyzed  the  quantitative  values  of  the  immune 
response as well as the correlation seen between them. Due 
to the small size of the groups, the significance of intergroup 
differences could not be determined. However, a comparison 
of the data has enabled the creation of an inferred picture of 
the immune response to mixed infection, including the various 
types of herpesviruses and those specific for episodic remittent 
paranoid schizophrenia compared with the unfavorably current 
form of episodic paranoid schizophrenia. 
Analysis of the parameters of the specific immune resistance
The  frequency  of  cases  with  a  positive  reaction  for 
antibodies  to  the  herpesviruses  in  the  groups  studied  are 
shown in Table 2. 
The reaction was considered positive if the antibody level was 
greater than the reference value (Table 3). 
In  both  groups  of  patients  with  schizophrenia,  the 
seropositive cases to HSV-1 and EBV were dominant, and in 
a lesser degree to the CMV. In the main group, the elevated 
serum  levels  of  the  HSV-1  IgG  antibodies  were  observed 
in 81% of the cases, the EBV IgG antibodies in 96% of the 
cases and the CMV IgG antibody in 31% of the cases. In the 
control group, the values of these parameters were 59%, 92% 
and 33%, respectively. The serum levels of the HSV-1 IgM 
antibodies exceeded that of the reference value in a few cases, 
whereas the serum levels of the IgM antibodies to the other 
viruses matched the reference values. The serum levels of the 
HSV-2 IgM antibodies corresponded to the reference values in 
both groups. The positive titers of the HSV-2 IgM antibodies 
were observed only in the main group in 14% of the patients. 
On the other hand, positive titers of the CMV IgM antibodies 
were detected in 14% of the patients in the control group and 
3.5% patients of the main group. The frequency of the elevated 
CMV IgG titers was similar in the groups (33% and 31%). 
The data shown in Table 3 indicate higher levels of the 
serum HSV-1 and HSV-2 IgG antibodies in the main group 
and were compared with the control group, without finding 
any statistical significance. The EBV IgG antibody levels were 
significantly higher than the reference values (approximately 
four-fold) in both groups. It is important to note that almost all 
the parameters of the specific IgM antibodies were above zero. 
It should also be noted that according to modern virologists’ 
findings, the levels of the specific IgM antibodies above zero 
clearly indicate an infectious process induced by the relevant 
agent. 
Thus,  these  indicators  of  specific  immune  resistance 
in both the groups did not exclude the possibility of a mixed 
infection involving several herpesviruses, especially the HSV-
1 and EBV. In the process of exacerbation in the main group, 
the role of HSV-2 was found to be more significant, whereas in 
the control group the CMV played a bigger role. 
The data in Table 4 suggest the presence of EBV infection 
without  any  correlations  with  other  infections  in  the  main 
group of patients. In the control group, a significant number 
of correlations was revealed between the antibody levels to all 
the viruses studied, except for the EBV. Synchronous changes 
Table 2. 
The frequency of cases with a positive reaction for antibodies
 to the herpesviruses in the groups studied.
Antibody  Virus ERPS EPSPSD Total
n % n % n %
IgG HSV-1 25 81 16 59 41 64
IgM 1 3.5 2 37 3 4.7
IgG HSV-2 4 14 0 0 4 6,3
IgM 0 0 0 0 0 0
IgM CMV 1 3.5 4 14 5 7.8
IgG 9 31 9 33 18 28
IgG EBV 29 96 25 92 54 84
IgM 0 0 0 0 0 0
Table 3.
The serum levels of the antibodies to the herpesviruses in the 
groups studied
Specific Ig
(U/ml) 
Herpesvirus Reference values ERPS EPSPSD
IgG
HSV-1
<9 - neg.  >9.8 – pos. 16.1±8.8 13.3±9.4
IgM <1 – neg. >1 - pos. 0.8±0.2 0.77±0.2
IgG
HSV-2
<6 – neg. >6.8 – pos. 3.0±2.5 2.0±1.1
IgM <1 – neg. >1 – pos. 0.76±0.21 0.71±0.2
IgM
CMV
<0.9 – neg. >1.1 –pos. 0.73±0.27 0.74±0.3
IgG <6 – neg. >6 – pos. 5.0±3.8 5.2±3.9
IgG
EBV
<1 – neg. >1 – pos. 4.0±2.2 4.3±2.5
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in the serum levels of IgM and IgG antibodies in response to 
the HSV-1 and CMV may reveal the active infection caused 
by these viruses. The negative correlation between the IgM 
and IgG antibodies to HSV-2 may reflect the phase shift of the 
specific humoral immune response to this virus in the active 
phase of the process. Positive correlations between the values 
of the IgG antibodies to that of the HSV-1 and HSV-2, the IgG 
antibodies to the HSV-2 and CMV, the IgM antibodies to the 
HSV-1 and HSV-2 is most easily explained by the synergism 
of the viruses indicated. In the literature the possibility of a 
cross-immune  response  to  these  viruses  is  suggested  [29], 
although the present study is limited for such conclusions.
Thus, the data given above most likely describes the 
exacerbation of a mixed infection involving the HSV-1, HSV-
2  and  CMV,  synergistically  interacting  with  one  another. 
This synergism is not observed for EBV due to the absence 
of appropriate correlations with the IgG antibodies. A large 
percentage of individuals with a high level of IgG antibodies 
to EBV (Table 2) and a high average value of IgG antibodies 
to the EBV (Table 3)  with a lack of correlation between the 
levels of the IgG and IgM antibodies to EBV may indicate the 
presence of chronic EBV infection with stable values of the 
specific antibodies. Thus, the activation of the HSV-1, 2 and 
CMV interacting synergistically is probably developed against 
the background of the chronic course of the EBV infection. 
It is important to pay attention to the conjugation of 
the  antibody  response  to  the  various  herpesviruses  in  the 
control group which probably indicates the joint activity of 
these viruses or a combination of their genetic material [33]. 
These data confirm the results of the experimental studies, 
which reveal the phenomenon of the interference viruses [29]. 
The data given in Table 4 indirectly indicate the cellular and 
phagocytic immune deficits in the control group against the 
background of the damaging effect of these viruses.
Analysis of the parameters of nonspecific immune resistance
Abnormalities in the immune status occurred in 80% of 
the patients in the main group and in 85% of patients in the 
control group. Deviations did not follow a specific characteristic 
pattern, except for the percentage of the lymphocytes. Thus, 
in the main group, lymphocytosis was noted in 47.8% of the 
cases and lymphopenia in 21% of the cases. These patients also 
revealed other signs of T-cell deficiency. In the control group, 
lymphocytosis was detected almost twice as less frequently 
(26.3%). Patients with lymphocytosis "have accumulated" the 
cases of other elevated parameters of cellular immunity. The 
remaining patients with normal lymphocyte levels revealed 
the  accumulation  of  cases  of  other  reduced  parameters  of 
cellular immunity. In particular, the reduction in the number of 
the T- helper cells in the control group occurred twice as often 
as in the main group (47.4% and 21.7%, respectively). In the 
control group, a slight increase in the CIC level was noticed 
in 40% of the cases and in 8% of the cases in the main group.
Thus, the data on the frequency of the abnormal values 
of  nonspecific  immunity  in    the  patients  studied  reflect  a 
combined character. The cases with the reduced parameters of 
cellular immunity are more common, especially in the control 
group. Overall, these results are consistent with Lobachyova 
[1] and other researchers regarding the nature of changes in 
the immunity in paranoid schizophrenia and their dependence 
upon clinical parameters. 
Analysis of the relationships between the parameters 
of immune resistance
In the main group (Table 5), the correlation analysis 
revealed  only  a  negative  correlation  present  between  the 
levels of the EBV IgM and IgG antibodies (r=-0.46), which 
could reflect the dynamics of change in the antibody formation     
(decrease  of  IgM  synthesis  and  increase  of  IgG  synthesis)  in 
response to the active infectious process associated with EBV. 
In the main group, the presence of a significant number of 
correlations  was  noted  between  the  nonspecific  resistance 
parameters that might indicate their relative coordination, as 
well as sufficient immune reactivity as a whole (Table 5). The 
presence of the correlations between the parameters of cellular 
immunity with the IgM antibodies and CIC may indicate an 
acute infection. The correspondence of the quantitative values 
of these parameters to the reference values in a significant 
number of patients does not exclude the immune deficiency 
characteristic of the herpes infection [25, 29, 31]. 
The  data  from  the  control  group  reflect  the  acute 
infectious process. Its originality lies in the combination of 
significant  correlations  between  the  parameters  of  cellular 
immunity with an insufficient number of correlations between 
the  parameters  of  the  other  components  of  immunity.  In 
particular, no correlation between the IgG antibodies and PhI, 
CIC, as well as between the percentage of B-lymphocytes and 
nonspecific  immunoglobulins  is  seen.  Such  features  of  the 
immune response may be due to the EBV influence on the 
immunocompetent cells [29, 34], and correspond to a high 
level of EBV IgG antibody in the control group (Table 3). 
Moreover, the lack of correlation between the CIC and PhI 
may imply an immunological tolerance to the infective agents 
[24]. The absence of elevated CIC levels may also reflect the 
functional defects of the phagocytic system. It should be noted 
that the correlations between the cellular immunity parameters 
were numerically quite small and the incoordination between 
the components of the immune system was more pronounced in 
the control group when compared with those of the main group. 
In  the  main  group,  the  increased  level  of  the  HSV-1  IgM 
antibodies was associated with the increased synthesis of the 
IgG antibodies (Table 6). This phenomenon could be explained 
Table 4. 
Correlations between antibody (Ab) levels to herpesviruses in the 
patient groups
Variable ERPS EPSPSD
Parameter 1 Parameter 2 r Parameter 2 r
HSV-1 IgG Ab - - HSV-1 IgM Ab 0.52*
HSV-2 IgG Ab 0.46*
CMV IgМ Ab 0.42*
HSV-1 IgM Ab - - HSV-2 IgM Ab -0.47*
HSV-2 IgG Ab - - HSV-2 IgM Ab 0.41*
- - CMV IgG Ab 0.49*
HSV-2 IgM Ab - - CMV IgG Ab 0.45*
EBV IgM Ab EBV IgM Ab -0.46* - -
*- р<0.05; ** - p<0.005255 I. I. Mikhailova et al / International Journal of BioMedicine 3(4) (2013) 251-257
by  the  presence  of  the  humoral  response  to  the  activation 
of  the  HSV-1  infection;  moreover,  the  frequency  of  cases 
with elevated HSV-1 IgG antibodies in this group was high 
(81%). However, the correlation with the total pool of IgG 
antibodies and lack of the correlation with HSV-1 specific IgG 
antibodies more likely support the assumption regarding the 
provocation of the HSV-1 infection with the other pathogens. 
Such an interpretation is consistent with the data considering 
the participation of pathogens such as toxoplasma, rubella, 
influenza, and other infectious agents in the pathogenesis of 
schizophrenia [18, 19, 35]. 
The main group of patients showed signs of activation 
of all the components of immunity in response to the HSV-2, 
viz., correlations between the levels of serum HSV-2 and the 
CIC content, the serum levels of HSV-2 IgM antibodies and 
the percentage content of the T-lymphocytes, T-helper cells, 
B-lymphocytes, and PhI. 
In accordance with the data in Tables 5 and 6, the immune 
response of the main group of patients was more harmonious 
and focused upon the acute HSV-2 infection, although indirect 
signs of intercurrent infection, which activated the HSV-1, 
were also observed. 
In  light  of  the  above  observation,  the  negative 
correlation noted between the EBV IgM antibodies and the 
EBV IgG antibodies in the absence of their relation with the 
parameters of non-specific immunity is very interesting. This 
correlation  indicates  the  presence  of  acute  EBV  infection. 
Under conditions of EBV infection, this statistical autonomy 
can be explained by the activation of the humoral immunity 
under induced T-cell apoptosis [32]. Signs of this phenomenon 
in conjunction with the frequency of EBV seropositivity may 
indicate persistent EBV infection. Further, it is important to 
consider the possibility of the presence of various intercurrent 
infections and the specific disruption of the immune response 
related to them.
For the control group, the polymorphic immune response 
to the mixed viral infection was more typical, viz., the signs 
of acute inflammation associated with the HSV-2 activation 
(a negative correlation between the serum levels of HSV-2 
IgM and IgA antibodies, the HSV-2 IgG antibodies and CIC, 
a positive correlation between the serum levels of HSV-2 IgM 
Table 5. 
Correlations between parameters of nonspecific immune resistance 
in the patient groups
Variable ERPS  EPSPSD
Parameter 1  Parameter 2 r Parameter 2 r
Т- lymphocytes, %Т- helpers, % 0.59* Т- helpers, % 0.72**
Т-killers/
suppressors, %
0.6** Т-killers/
suppressors, %
0.62**
Phagocytic index 0.54** - -
- - Т-helpers/μl 0.86**
- - Т-killers/
suppressors/μl
0.75**
- - Natural killers/μl 0.57*
Т- lymphocytes/μl Т-helpers/μl 0.93** - -
Т- killers/
suppressors/μl
0.94** Т- killers/
suppressors/μl
0.87**
Natural killers/μl 0.68** Natural killers/μl 0.79**
В- lymphocytes/μl 0.8** В- lymphocytes/μl 0.71**
IgM -0.6** - -
Phagocytic index 0.53** - -
Lymphocytes, % 0.58** Lymphocytes, % 0.6**
Lymphocytes 10x9/l 0.91** Lymphocytes 10x9/l 0.75**
- - IgA -0.56*
Т- helpers, % IgМ -0.45* - -
Т-helpers/μl Т- killers/
suppressors/μl
0.82** - -
Natural killers/μl 0.78** Natural killers/μl 0.64**
В- lymphocytes/μl 0.85** В- lymphocytes/μl 0.76**
IgМ -0.63* - -
Phagocytic index 0.5* - -
Leukocytes 10x9/l 0.64* Leukocytes 10x9/l 0.58*
Lymphocytes, % 0.52* Lymphocytes, % 0.73**
Lymphocytes 10x9/l 0.94** Lymphocytes 10x9/l 0.95**
Т- killers/
suppressors,%
В- lymphocytes/μl 0.44** - -
Т- killers/
suppressors/μl
Natural killers/μl 0.57** Natural killers/μl 0.57*
В- lymphocytes/μl 0.8** - -
Leukocytes 10x9/l 0.59* - -
IgМ -0.5*  - -
Phagocytic index 0.4* - -
Lymphocytes, % 0.5* Lymphocytes, % 0.67*
Leukocytes 10x9/l 0.63* Leukocytes 10x9/l 0.59*
Lymphocytes 10x9/l 0.81** Lymphocytes 10x9/l 0.96**
Natural killers/μl В- lymphocytes/μl 0.6** В- lymphocytes/μl 0.79**
IgМ -0.48* - -
Lymphocytes, % 0.47* Lymphocytes, % 0.5*
Lymphocytes 10x9/l 0.71** Lymphocytes 10x9/l 0.76**
- - Leukocytes 10x9/l 0.5*
Natural killers, % - - Natural killers/μl 0.57*
- - В-лимфоциты % 0.47*
Phagocytic index Lymphocytes 10x9/l 0.47* Lymphocytes 10x9/l 0.85**
Leukocytes 10x9/l 0.43* Neutrophils 10x9/l 0.84**
Lymphocytes, % Neutrophils 10x9/l -0.53* Neutrophils 10x9/l -0.53*
В- lymphocytes,%Phagocytic index 0.53** - -
В- lymphocytes/μlPhagocytic index 0.5** - -
Leukocytes 10x9/l 0.5** - -
Lymphocytes, % 0.54** -
Lymphocytes 10x9/l 0.78** - -
IgМ Lymphocytes 10x9/l-0.56** - -
CIC (3% PEG) Leukocytes 10x9/l 0.6** - -
Neutrophils 10x9/l 0.5* - -
Leukocytes 10x9/l Lymphocytes 10x9/l 0.61** - -
Neutrophils 10x9/l 0.86** -
 * - р<0.05;
 ** -  p<0.005
Table 6.
Correlations  between  parameters  of  specific  and    nonspecific 
immune resistance in the patient groups
Variable ERPS  EPSPSD
Parameter 1 Parameter 2 r Parameter 2 r
HSV-1 IgM Ab IgG Ab 0.46* - -
- - Natural killers,% -0.55*
HSV-2 IgM Ab Т- lymphocytes, % 0.63** Т- lymphocytes, % 0.5*
Т- helpers, % 0.57** - -
В- lymphocytes,% 0.47* - -
Phagocytic index 0.64** - -
- - IgА Ab -0.48*
HSV-2 IgG Ab CIC (3% PEG) -0.42* CIC (3% PEG) -0.52*
CMV IgM Ab - - Natural killers,% -0.5*
EBV IgG Ab - - IgА Ab 0.51*
*- р<0.05; ** - p<0.005256                                          I. I. Mihkailova et al / International Journal of BioMedicine 2(4) (2013) 251-257
antibodies and the percentages of the T-lymphocytes). The 
negative correlation between the serum level of HSV-1 IgM 
antibodies and the percentage of the neutrophils may indicate 
the depression of the effector stage of the immune response 
when phagocytosis is activated, as well as the production of 
T-suppressors is increased. 
The positive correlation between the serum levels of 
the EBV IgG antibodies and the EBV IgA antibodies most 
likely reflects the presence of the EBV infection with virus 
replication  in  the  epithelial  cells.  The  negative  correlation 
between the serum levels of the CMV IgM antibodies and the 
percentage of the natural killer cells indicates the activation of 
phagocytic immunity during the period of the acute infectious 
process.
Thus,  in  patients  with  an  acute  episode  of  Episodic 
Remittent  Paranoid  Schizophrenia,  the  exacerbation  of 
persistent infection of a mixed nature accompanied by the 
significant  role  of  the  herpesviruses  was  revealed.  The 
immune response was characterized by the relative integrity 
of reactivity and coordination in the operation of various units 
of immunity. However, the signs of heterogeneity were also 
marked. In particular, if the response to the HSV-2 is quite 
harmonious, the response to the HSV-1 and EBV infection 
will be predominantly humoral. The symptoms of immunity 
deformation (general insufficiency of the immune response 
intensity  and  the  local  insufficiency  of  cellular  immunity) 
described  may  be  associated  with  the  persistence  of  the 
herpesviruses. 
Analysis  of  the  nonspecific  and  specific  immune 
resistance parameters in patients with an unfavorable course 
of  episodic  paranoid  schizophrenia  revealed  signs  of  the 
chronic  infectious  process  involving  the  association  of  the 
herpesviruses (HSV-1, HSV-2, CMV)  and VEB against the 
backdrop of deficiency in the cellular and phagocytic immune 
response, as well as its disorganization. 
Conclusion
The results of this study indicate the presence of mixed 
infection involving several herpesviruses (HSV-1, HSV-2, CMV, 
EBV) against the background of partial immunosuppression in 
those patients with paranoid schizophrenia in both groups.
With  persistence,  the  tropism  of  the  herpesviruses 
discussed to the immunocompetent cells contributes to the 
development  of  secondary  immune  deficiency.  The  origin 
of  the  primary  immune  deficiency,  however,  continues  to 
remain  unclear.  The  hypotheses  of  hereditary  and  viral 
immune deficiency can be combined with the possibility of 
the integration of viral genetic material into the host DNA 
with subsequent transfer by succession; the phenomenon of 
immune imprinting should also be considered [10, 17]. 
Our  study  revealed  several  inter-group  differences 
regarding the nature of the interaction of the herpesviruses 
with the macroorganism, the interaction between viruses, and 
the characteristic features of immune deficiency. Thus, if the 
patients in the main group possessed several “superimposed” 
immune  responses  to  different  pathogens  (including  EBV) 
in acute infectious processes, the control group of patients 
revealed the association of the HSV-1, HSV-2, and CMV with 
a synergistic effect. The immune response in the control group 
is perceived as being rarer due to the greater and more severe 
lack  of  all  the  components  of  immunity  and  the  violation 
of  consistency  between  them.  These  features  correspond 
to the signs of chronic EBV infection and the presence of 
opportunistic CMV infection.
The results of the study enable us to conclude regarding 
the  connection  between  specific  herpesviruses  with  the 
clinical features of schizophrenia. Thus, in both groups, the 
HSV-2 was found to be the most important in the pathogenesis 
of  disease  exacerbation.  The  nature  of  the  EBV  infection 
reveals  a  connection  with  the  type  of  schizophrenia.  It 
should be noted that EBV infection enhances the stability of 
the infected B-lymphocytes to apoptosis and their potential 
to  stimulate  polyclonal  autoantibody  formation  [31].  The 
results of our study support that a marked trend towards the 
development of the autoimmune processes with an increase in 
the duration of schizophrenia associated with EBV infection. 
The results thus obtained can consider the herpesviruses as an 
important etiopathogenic factor of various clinical forms of 
episodic schizophrenia. These findings are consistent with the 
previously mentioned results, which revealed the variation in 
the severity of the psychopathological symptoms according to 
the serum levels of the antibodies to the herpesviruses [20]. 
The  present  study  determines  the  relevance  of  a 
multidisciplinary approach to the study of schizophrenia based 
on the etiopathogenic role of the viral factors and the advisability 
of the inclusion of antiviral and immunomodulatory drugs in 
the treatment algorithm of schizophrenia.
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